Katalin Pallagi - Concepedia

Author

Katalin Pallagi

Egis Pharmaceuticals (Hungary)

Also Known As

K Pallagi, Katalin Pallagi

Publications

327

Citations

H-Index

Concepts

All Affiliations

Egis Pharmaceuticals (Hungary)Servier (France)HUN-REN Institute of Experimental Medicine Hungarian Academy of Sciences Institut des Hautes Études Scientifiques

About

Katalin Pallagi is an author at Egis Pharmaceuticals (Hungary) specializing in medicine, pharmacology, and neuropharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	244
2	Social Sciences	2	2	46
3	Natural Sciences	1	1	99
4	Biochemistry	1	1	99
5	Biomolecular Engineering	1	1	28

Katalin Pallagi

Publications

297

Citations

H-Index

Page 1

	Year	Citations
(Phenylpiperazinyl-butyl)oxindoles as Selective 5-HT<sub>7</sub> Receptor Antagonists Balázs Volk, József Barkóczy, Endre Hegedűs, Journal of Medicinal Chemistry Combinatorial ChemistryMolecular PharmacologyMedicinal ChemistryOxindole SkeletonBiochemistry	2008	99
Selective inhibition of extra-synaptic α5-GABA A receptors by S44819, a new therapeutic agent Lori‐An Etherington, Balázs Mihalik, Adrienn Pálvölgyi, Neuropharmacology Selective InhibitionMolecular PharmacologySynaptic PlasticityNew Therapeutic AgentG Protein-coupled Receptor	2017	54
Optimization of (Arylpiperazinylbutyl)oxindoles Exhibiting Selective 5-HT<sub>7</sub>Receptor Antagonist Activity Balázs Volk, István Gacsályi, Katalin Pallagi, Journal of Medicinal Chemistry	2011	53
A novel GABAA alpha 5 receptor inhibitor with therapeutic potential István Ling, Balázs Mihalik, L.-A. Etherington, European Journal of Pharmacology Functional SelectivityMedicineDrug DiscoveryG Protein-coupled ReceptorMechanism Of Action	2015	28
Alterations in Brain Extracellular Dopamine and Glycine Levels Following Combined Administration of the Glycine Transporter Type-1 Inhibitor Org-24461 and Risperidone Katalin Nagy, Bernadett Markó, G. Zsilla, Neurochemical Research NeurophysiologyMedicineNeurotransmitterPsychopharmacologyNeuropharmacology	2010	26
Egis-11150: A candidate antipsychotic compound with procognitive efficacy in rodents István Gacsályi, Katalin Nagy, Katalin Pallagi, Neuropharmacology Psychoactive DrugPsychiatryPsychotropic MedicationPsychopharmacologySchizophrenia	2012	20
5-HT6/7 Receptor Antagonists Facilitate Dopamine Release in the Cochlea via a GABAergic Disinhibitory Mechanism Zoltán Doleviczényi, E. Sylvester Vizi, István Gacsályi, Neurochemical Research Functional SelectivityMedicinePhysiologyNeurotransmitterGabaergic Disinhibitory Mechanism	2008	17

Page 1